GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 10:07 am Sale | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | GILDER GAGNON HOWE & CO LLC | 1,470,841 4.060% | -356,360 (-19.50%) | Filing |